Navigation Links
Indian pharma industry upbeat on WTO drug deal

vide flexibility to the developing countries -- even flexibility to countries that aren't necessarily the poorest -- to address serious public health problems.

''It is really good news from the humanitarian point of view as it will serve a world of difference so far as treating dreaded diseases are concerned,'' observed Hyderabad-based Dr Reddy's Labs spokesman.
'"/>




Page: 1 2

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian Treatment for Iraqi Babies
11. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
Post Your Comments:
(Date:7/25/2008)... Management to discuss second quarter financial re.../ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today ...riday, August 8 at 8:30 a.m. (ET) to discuss its s...ll report its second quarter 2008 financial,result...same day., To access the conference call by telep...
(Date:7/25/2008)...f certain cleaning products reduces lung function,... , FRIDAY, July 25 (HealthDay News) -- A clean, ...ealth, depending on what type of cleaning and air ...suggests that exposure to cleaning products or air...c compound (VOC) called 1,4 dicholorobenzene (1,4 ...
(Date:7/25/2008)...ALLAS, July 25 /PRNewswire/ -- BeaconEquity.com an... making news today., Investors can view all of th...//BeaconEquity.com/m , Today,s Trade Alerts inclu...ddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK ), N... ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abax...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Beg...all/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI )...unced today that its subsidiary has commenced comm...Capsules USP product in the 40mg,strength from its...tion,with the launch, Watson has 180 days of marke...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2
...ot find the much needed reprieve yet. There are no...atening to plunge Queensland into a// deeper crisi...espite Premier Peter Beattie’s promises to the con...ike mere rhetoric when the Premier promised to bea...
... has become the number one killer. More so, relate...n occupational Hazard// with millions of people ru...place of work. Inhaling asbestos fibers and second...according to a WHO reports. Thousands develop leuk...
... the death of six pre-term babies in Quebec has fi...re the incidents// occurred-Quebec’s Sainte- Justi...g in faulty sinks of the neo-natal intensive care ...sa was discovered to be breeding in colonies withi...
...etic risk factors for type 2 diabetes to date, a U...ith two other groups, has identified// at least fo...risk of diabetes and confirmed existence of anothe...d simultaneously today in the online edition of th...
Other Medicine News:Health News:Today Cancer is the Deadliest Killer 2Health News:Tiny Lives Snuffed Out Due To Bad Plumbing 2Health News:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 2Health News:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 3Health News:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 4Health News:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 5Health News:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 6
(Date:7/22/2008)... 22 /- Following a,thorough...f Progen,Pharmaceuticals Limited (ASX: PGL; Nasdaq...he PI-88 phase 3 study in liver cancer. Progen con...ting portfolio of compounds and,the company will a...pportunities through Merger & Acquisition activity...
(Date:7/22/2008)...peutics Development Initiative bring MJFF,s,curren...ine January 20,2009, NEW YORK, July 22 /PRNewswi...delivery of transformative treatments and a cure f...ion for Parkinson,s Research has awarded,$2.7 mill...s. The awards,were granted under MJFF,s Therapeuti...
(Date:7/22/2008)... Confirms Tyrima Exhibits Excellent Drug-Like ...lts Support Initiation of Phase II Clinical Trials...wire/ -- CeNeRx BioPharma,Inc., a clinical stage ...treatments for diseases of the central nervous sys...didate Tyrima(TM) into Phase II trials for the,tre...
(Date:7/22/2008)...f., July 22 /- Hyperion,Therapeutics,...t enrollment,in its Phase 1/2 clinical trial to ev...ging effects of HPN-100 (formally called GT4P) ver...s with urea cycle disorders,(UCD). The company pla...ter,of this year., (Logo: http://www.newscom.com...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Easy Does It Eases Holiday Stress 8766 1Easy Does It Eases Holiday Stress 8766 2Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 1Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 2Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 3Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 1Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 2Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 3Gold nanoparticle probes may allow earlier cancer detection 8756 1Gold nanoparticle probes may allow earlier cancer detection 8756 2Gold nanoparticle probes may allow earlier cancer detection 8756 3
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
...nd large backrests with lumbar support • Sele...sters and glides. • Choose the BE Series for ...ding: industry, education, laboratory, clean room,...th cast aluminum base • unit standard with ca...
...nd large backrests with lumbar support • Sele...sters and glides. • Choose the BE Series for ...ding: industry, education, laboratory, clean room,...th cast aluminum base • unit standard with ca...
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Medicine Products: